China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Update

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTCGet Free Report) was the target of a large increase in short interest in June. As of June 15th, there was short interest totalling 49,500 shares, an increase of 43.1% from the May 31st total of 34,600 shares. Currently, 9.3% of the company’s stock are short sold. Based on an average trading volume of 1,070,000 shares, the days-to-cover ratio is presently 0.0 days.

China SXT Pharmaceuticals Trading Down 1.8 %

SXTC stock opened at $1.09 on Monday. The business has a 50-day simple moving average of $1.08 and a two-hundred day simple moving average of $1.63. China SXT Pharmaceuticals has a 52-week low of $0.94 and a 52-week high of $9.38.

China SXT Pharmaceuticals Company Profile

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

See Also

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.